AI assistant
STARSOURCE MULTITRADE LIMITED — Board/Management Information 2025
Sep 12, 2025
63364_rns_2025-09-12_0a320f68-7f74-4889-8207-8633b0afa600.pdf
Board/Management Information
Open in viewerOpens in your device viewer
CHEMO PHARMA LABORATORIES LTD
Registered Office : 5-Kumud Apartment Co. Op. HSG. SOC. Ltd, Karnik Road, Chikan Ghar, Kalyan, Dist. Thane – 421301
Corporate Office: Office No 1016 North Plaza Near D Mart, Visat Gandhinagar Highway, Motera, Ahmedabad, Gujarat, India, 380005
Tel No.:022-22078382 [CIN: L99999MH1942PLC003556]
Website: www.thechemopharmalaboratoriesltd.com Email : [email protected] Date: September 12, 2025
To, Bombay Stock Exchange Limited Department of Corporate Services, 25th Floor, P. J. Towers, Dalal Street, Mumbai-400001 Script Id: 506365 ISIN: INE320M01019
Subject: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Company Secretary & Compliance Officer
Dear Sir,
Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you that Ms. Bhawna Rajput (ACS 72357) has tendered her resignation from the post of Company Secretary and Compliance Officer of the company vide her letter dated September 12, 2025 to due to preoccupancy in other assignments. The Company has accepted and taken on record her resignation and will complete necessary formalities in regards of her resignation in due course of time. She will be relieved from her responsibilities w.e.f. September 12, 2025. Copy of her resignation letter is enclosed herewith.
The details required under the SEBI Listing Regulations and SEBI Circular No. SEBI/HO/ CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July 2023 (‘SEBI Circular) are attached herewith as Annexure A .
Further, the Board of Directors of the Company in their Board Meeting held on today i.e. Friday, September 12, 2025 which was commenced at 03.15 PM at the registered Office of the Company have considered and have, inter alia, approved appointment of Mr. Aditya Agarwal (ACS 53202) as Company Secretary & Compliance Officer of the Company w.e.f. September 12, 2025. The Details for the above mentioned required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015) are given in Annexure B . Please note that the meeting concluded at 03.45 PM.
Kindly take the same on your records.
Thanking You. Yours Faithfully,
FOR CHEMO PHARMA LABORATORIES LIMITED
==> picture [109 x 26] intentionally omitted <==
==> picture [73 x 66] intentionally omitted <==
RUCHIT MEHTA Managing Director & Chief Executive Officer DIN: 08810586
Annexure A
Details pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Read with Schedule III of these Regulations and SEBI circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123, dated 13th July, 2023 with respect to resignation of Company Secretary & Compliance Officer of the Company
| Sr. No. | Particulars | Details |
|---|---|---|
| 1 | Name ofthe Company | ChemoPharmaLaboratoriesLimited |
| 2 | Name ofCompany Secretary | Ms.BhawnaRajput (ACS72357) |
| 3 | Reasons of change viz. appointment, resignation, removal, deathorotherwise |
Pre-occupation in other assignments as mentioned in resignation letter dated September 12, 2025. |
| 4 | Effective date of resignation | September 12, 2025. |
| 5 | Briefprofile | Not applicable |
| 6 | Disclosure of relationship between directors (in case of appointment ofa director |
Not applicable |
| 7 | Information as required pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/ 2018- 19 and the National Stock Exchange of India Ltd with ref. no. NSE/CML/2018/24, dated 20th June 2018 |
Not Applicable |
==> picture [73 x 66] intentionally omitted <==
==> picture [414 x 250] intentionally omitted <==
==> picture [414 x 250] intentionally omitted <==
Annexure B
Information as required in terms of the Circular under Regulation 30 of Listing Regulations: Appointment of Mr. Aditya Agarwal (ACS 53202) as a Company Secretary and Compliance officer of the Company.
| Sr. No. | Particulars | Details |
|---|---|---|
| 1 | Name ofthe Company | ChemoPharmaLaboratoriesLimited |
| 2 | Name ofCompany Secretary | Mr.AdityaAgarwal(ACS 53202) |
| 3 | Reasons of change viz. appointment, resignation, removal, death or otherwise |
Mr. Aditya Agarwal has been appointed as a Company Secretary & Compliance Officer by the Board with effect from September 12, 2025 |
| 4 | Date of Appointment & Terms of appointment |
September 12, 2025. |
| 5 | Brief profile | Mr. Aditya Agarwal is a qualified Company Secretary with expertise in legal, secretarial, and listing compliances, complemented by an MBA & M.Com degree. Possesses experience with a proven ability to independently manage statutory requirements while contributing to organizational growth. A collaborative team player with an ownership mindset and a focus on delivering high quality strategic solutions to complexchallenges. |
| 6 | Disclosure of relationship between directors (in case of appointment ofa director |
Not related to any existing directors of the Company. |
| 7 | Information as required pursuant to BSE Circular with ref. no. LIST/COMP/14/2018-19 and the National Stock Exchange of India Ltd with ref. no. NSE/CML/2018/24, dated 20th June 2018 |
Not Applicable |
==> picture [73 x 66] intentionally omitted <==